PROM1 and central nervous system cancer: Moreover, secondary GBM and grade 3 gliomas exhibited greater microarray similarity to GSCs than did de novo GBM (Fig. S1C), whereas CD133 expression is reportedly more prevalent in de novo GBM [29].